ELANE antibody
Quick Overview for ELANE antibody (ABIN2192035)
Target
See all ELANE AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Sterility
- 0.2 μm filtered
-
-
-
-
Application Notes
- For Western blotting dilutions to be used depend on detection system applied. It is recommended that users test the reagent and determine their own optimal dilutions. The typical starting working dilution is 1:50.
-
Restrictions
- For Research Use only
-
-
-
Buffer
- PBS, containing 0.02 % sodium azide and 0.1 % bovine serum albumin.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C
-
Storage Comment
- Product should be stored at 4 °C. Under recommended storage conditions, product is stable for one year.
-
Expiry Date
- 12 months
-
-
- ELANE (Elastase, Neutrophil Expressed (ELANE))
-
Alternative Name
- Leukocyte Elastase
-
Background
- The monoclonal antibody 265-3K1 recognizes human leukocyte elastase. Leukocyte elastase, a major serine proteinase in man, is predominantly present in the azurophilic granules of neutrophils and monocytes. Elastase has a broad range of extracellular matrix substrates including elastin, proteoglycans, collagen and fibronectin. The action of elastase is controlled by serine proteinase inhibitors. Elastase, when released during inflammation, is rapidly bound by its two main inhibitors, alpha1-PI and alpha2-macroglobuline to form elastase-inhibitor complexes. In addition mucosa secretions may contain the locally secreted elastase inhibitors elafin/SKALP and SLPI. When secreted at sites of inflammation elastase can cause severe tissue damage. An important role has been suggested for human elastase in various inflammatory disorders, including pulmonary emphysema, sepsis, arthritis, nephritis and certain skin diseases. Elastase induces the production of IL-8 in human bronchial epithelial, a proces that occurs in part through TLR4.
Target
-